All News


All series


All All News

Combination Therapy with Enzalutamide Yields 31 Percent Improvement in Radiological Progression-Free Survival for mCRPC

For patients with metastatic castration-resistant prostate cancer (mCRPC) and bone metastasis, the combination of enzalutamide and Ra223 led to a median overall survival rate of 42.3 months in contrast to 35 months for enzalutamide alone, according to research presented at the 2024 European Society for Medical Oncology Congress (ESMO) in Spain.

The Nonexistence of Perfect Balance in Radiology

In the elusive pursuit of reconciling case volume and having an appropriate number of radiologists, the proverbial windsurfer may fare better than stand-up paddleboarders and daredevil surfers at navigating the waves of the profession.

Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?

The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.